MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, PYXS has $64,300K in assets. $33,032K in debts. $5,766K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
275.66%
Quick Ratio
275.66%
Cash Ratio
34.88%
Debt to Asset Ratio
51.37%
Unit: Thousand (K) dollars
Assets Breakdown
    • Marketable debt securities
    • Operating lease right-of-use ass...
    • Property and equipment, net
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Operating lease liabilities, net...
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
5,766 15,422 8,919 10,733
Marketable debt securities
35,252 51,435 67,337 78,211
Restricted cash
1,472 1,472 1,472 1,472
Accounts receivable
---3,000
Prepaid expenses and other current assets
3,082 3,776 5,345 6,540
Total current assets
45,572 72,105 83,073 99,956
Property and equipment gross
-15,004 --
Less accumulated depreciation and amortization
-7,007 --
Property and equipment, net
7,538 7,997 8,460 8,924
Intangible assets, net
-0 2,434 2,488
Operating lease right-of-use asset
11,190 11,418 11,637 11,847
Total assets
64,300 91,520 105,604 123,215
Accounts payable
4,989 10,885 9,756 9,412
Accrued expenses and other current liabilities
9,786 8,554 7,996 6,698
Operating lease liabilities, current portion
1,757 1,692 1,630 1,568
Total current liabilities
16,532 21,131 19,382 17,678
Operating lease liabilities, net of current portion
16,497 16,958 17,400 17,832
Financing lease liabilities, net of current portion
3 23 43 62
Total liabilities
33,032 38,112 36,825 35,572
Common stock, 0.001 par value per share 190,000,000 shares authorized 62,831,246 and 62,690,229 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively
63 63 62 62
Additional paid-in capital
497,654 496,469 493,719 490,654
Accumulated other comprehensive income
0 53 69 -5
Accumulated deficit
-466,449 -443,177 -425,071 -403,068
Total stockholders' equity
31,268 53,408 68,779 87,643
Total liabilities and stockholders' equity
64,300 91,520 105,604 123,215
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable debt securities$35,252K Cash and cashequivalents$5,766K Prepaid expenses andother current assets$3,082K Restricted cash$1,472K Total current assets$45,572K Operating leaseright-of-use asset$11,190K Property and equipment,net$7,538K Total assets$64,300K Total liabilities andstockholders' equity$64,300K Total liabilities$33,032K Total stockholders'equity$31,268K Accumulated deficit-$466,449K Total currentliabilities$16,532K Operating leaseliabilities, net of current...$16,497K Financing leaseliabilities, net of current...$3K Additional paid-in capital$497,654K Common stock, 0.001 parvalue per share...$63K Accrued expenses andother current...$9,786K Accounts payable$4,989K Operating leaseliabilities, current portion$1,757K

Pyxis Oncology, Inc. (PYXS)

Pyxis Oncology, Inc. (PYXS)